Stocksigma LogoStocksigma Logo

Gennex Laboratories Reports Q2 Results and Committee Reconstitutions

Gennex Laboratories approved unaudited Q2 results for the period ended 30th Sep'26. Consolidated revenue from operations grew 13.5% YoY to ₹4,226.47 lakhs

Gennex Laboratories Reports Q2 Results and Committee Reconstitutions

Gennex Laboratories Ltd · Outcome · 14 Nov 2026, 11:57 pm

Gennex Laboratories Reports Q2 Results and Committee Reconstitutions Gennex Laboratories approved unaudited Q2 results for the period ended 30th Sep'26. Consolidated revenue from operations grew 13.5% YoY to ₹4,226.47 lakhs from ₹3,724.21 lakhs, while net profit declined 11.6% YoY to ₹486.93 lakhs compared to ₹551.15 lakhs. On a standalone basis, revenue rose 4.9% YoY to ₹3,076.26 lakhs, with net profit at ₹335.15 lakhs versus ₹453.32 lakhs in Q2 FY26. Additionally, the board reconstituted its Audit, Nomination & Remuneration, and Stakeholders Relationship Committees, while dissolving the Rights Issue Committee.

Original exchange filing (PDF)

More announcements from Gennex Laboratories Ltd

All Gennex Laboratories Ltd announcements